Engineered immune cells take on tough blood cancers
Disease control
Recruiting now
This early-stage trial tests a new treatment called CD1a-CAR T cells for people with T-cell acute lymphoblastic leukemia or lymphoma that has come back or not responded to standard therapy. The treatment involves taking a patient's own immune cells, modifying them to recognize an…
Phase: PHASE1 • Sponsor: OneChain Immunotherapeutics • Aim: Disease control
Last updated Apr 26, 2026 19:37 UTC